[1]
Y. Sang, “Pharmacokinetics and Pharmacological/Bioactive Studies of Oridonin Derivatives in Anti-tumor Research”, TMBLS, vol. 4, pp. 167–177, Aug. 2024, doi: 10.62051/cne0eh26.